Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Inozyme Pharma shares are trading higher after the company announced that the FDA granted Fast Track designation to INZ-701 for the treatment of ABCC6 Deficiency.

Author: Benzinga Newsdesk | July 02, 2024 08:34am

Posted In: INZY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist